Bomedemstat
Imago BioSciences
[]
$imgo 8-k imago biosciences (10 jun, 6:05am) imago biosciences presents positive data from ongoing phase 2 study of bomedemstat in essential thrombocythemia at eha 2022 #imgo #8k #imagobiosciences #news
Feed of new SEC filings and other useful information for stock market investors.